Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

IDX/MDLA stock hub

IDX/MDLA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/MDLAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.2T

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/MDLA

In the news

Latest news · IDX/MDLA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7.9

P25 9.4P50 14.4P75 23.9

Trailing P/E8

P25 11.5P50 23.8P75 52.6

ROEn/a

P25 0.6P50 5.1P75 12.2

ROIC16.4

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/MDLA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

190

Groups with data

Currency

IDR

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	2,224
Employees Change	-250%
Employees Change Percent	-10.11
Enterprise value	IDR 2.6T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Distribution
Isin	ID1000209901
Last refreshed	2026-05-10
Market cap	IDR 3.2T
Price	IDR 230
Price currency	IDR
Rev Per Employee	6,823,356,948.23x
Sector	Healthcare
Sic	2834
Symbol	idx/MDLA
Website	https://www.medela-potentia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	12.37%
EV Earnings	6.61x
EV/EBIT	5.25x
EV/EBITDA	4.47x
EV/FCF	-18.45x
EV/Sales	0.18x
FCF yield	-4.43%
Forward P/E	7.93x
P/B ratio	1x
P/E ratio	8.01x
P/S ratio	0.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.34%
EBITDA Margin	3.6%
Gross margin	9.6%
Gross Profit	IDR 1.4T
Gross Profit Growth	8.29%
Gross Profit Growth Q	17.89%
Net Income	IDR 398.6B
Net Income Growth	17.14%
Net Income Growth Q	35.43%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	3.49%
Profit Margin	2.65%
Profit Per Employee	IDR 181M
Profitable Years	5
ROCE	15.15
ROIC	16.38
Roic5y	22.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	22.88%
EPS Growth	-18.42
EPS Growth Q	-13.02
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth	-75.72%
Revenue Growth	5.95x
Revenue Growth Q	18.81x
Revenue Growth Quarters	1x
Revenue Growth Years	4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	IDR 6.9T
Cash	IDR 741B
Current Assets	IDR 6.3T
Current Liabilities	IDR 3.6T
Debt	IDR 78.2B
Debt EBITDA	IDR 0.13
Debt Equity	IDR 0.02
Debt FCF	IDR -0.55
Equity	IDR 3.2T
Interest Coverage	55.48
Liabilities	IDR 3.7T
Long Term Assets	IDR 622.6B
Long Term Liabilities	IDR 93.7B
Net Cash	IDR 662.8B
Net Cash By Market Cap	IDR 20.57
Net Cash Growth	652.34%
Net Debt EBITDA	IDR -1.23
Net Debt Equity	IDR -0.21
Tangible Book Value	IDR 3.1T
Tangible Book Value Per Share	IDR 224

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.75
Net Working Capital	IDR 2T
Quick ratio	0.97
Working Capital	IDR 2.7T
Working Capital Turnover	IDR 7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-43.59%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	IDR 9.8
Dividend Years	1
Dividend Yield	4.26%
Last Dividend	IDR 9.8
Payout Ratio	34.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	22.86%
200-day SMA	233
50-day SMA	218.9
50-day SMA vs 200-day SMA	50under200
All Time High	318
All Time High Change	-27.67%
All Time High Date	2025-08-25
All Time Low	179
All Time Low Change	28.49%
All Time Low Date	2025-04-15
ATR	11.09
Beta1y	0.52
Beta2y	0.5
Ch YTD	-12.88
High	254
High52	318
High52 Date	2025-08-25
High52ch	-27.67%
Low	226
Low52	180
Low52 Date	2025-07-22
Low52ch	27.78%
Ma50ch	5.06%
Price vs 200-day SMA	-1.29%
RSI	61.17
RSI Monthly	0
RSI Weekly	52.17
Sharpe ratio	0.68x
Sortino ratio	1.51
Total Return	-39.33%
Tr YTD	-12.88
Tr1m	8.49%
Tr1w	4.55%
Tr3m	-6.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR 502.4B
Operating Income Growth	10.4
Operating Income Growth Q	32.79
Operating margin	3.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,750,113,600%
Net Borrowing	-186,887,000,000
Shares Insiders	21.06%
Shares Institutions	1%
Shares Out	14,012,825,000
Shares Qo Q	-0.06%
Shares Yo Y	43.59%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR -142.8B
Average Volume	3,218,545x
Bv Per Share	224.6
CAPEX	IDR -226B
Ch1m	8.49
Ch1w	4.55
Ch1y	16.75
Ch3m	-6.5
Ch6m	-2.54
Change	-4.17%
Change From Open	-3.36
Close	240
Days Gap	-0.83
Depreciation Amortization	38,208,000,000
Dollar Volume	4,099,543,000
Earnings Date	2026-05-13
EBIT	IDR 502.4B
EBITDA	IDR 540.6B
EPS	IDR 28.72
F Score	4
FCF	IDR -142.8B
FCF EV Yield	-5.42x
FCF Per Share	IDR -10.19
Financing CF	313,795,000,000
Fiscal Year End	December
Founded	2,011
Graham Number	380.98083
Graham Upside	65.64
Income Tax	IDR 118.5B
Investing CF	-548,438,000,000
Is Primary Listing	1
Last Report Date	2026-03-31
Ma150	238.3
Ma150ch	-3.49%
Ma20	216.2
Ma20ch	6.38%
Net CF	-146,563,000,000
Next Earnings Date	2026-05-13
Open	238
P OCF Ratio	38.73
Payment Date	2025-07-30
Position In Range	14.29
Ppne	582,573,000,000
Price Date	2026-05-08
Price EBITDA	IDR 5.96
Ptbv Ratio	1.03
Relative Volume	5.97x
Revenue	15,025,032,000,000x
Tax By Revenue	0.79x
Tax Rate	22.58%
Tr6m	-2.54%
Volume	17,824,100
Z Score	3.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

IDX/MDLA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.3%

$9.80 annual per share

Payout ratio

+34.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-39.3%

Dividend yield + buyback yield combined

Performance

IDX/MDLA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/MDLA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.0%

Share of float held by funds and institutions

Insider ownership

+21.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+43.6%

Negative means the company is buying back shares.

Technical

IDX/MDLA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.2

Neutral momentum band

Price vs 200-day MA

-1.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/MDLA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/MDLA stock rating?

idx/MDLA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/MDLA analysis?

The full report lives at /stocks/idx/MDLA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/MDLA?

The latest report frames idx/MDLA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/MDLA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.